Answers are grounded in this paper and cite their sources.
Narrative review examines cognitive impairment after breast cancer treatment, highlighting intervention strategies and mechanisms.
Cancer-related cognitive impairment (CRCI) is a common complaint in breast cancer patients, especially related to chemotherapy. It is characterized as cognitive disorders in areas of memory, attention and executive function, which can negatively affect patients' quality of life and their ability to work. While various assessment methods of CRCI cause highly diverse results in CRCI-related studies. Currently, it is not clear how cerebral structure and function change in breast cancer patients and underlying mechanisms of developing CRCI are still undefined. Intervention research is limited. This article reviews the results of CRCI-related studies and research progress and discusses the advantages and limits of various methods. Besides, the mechanisms and intervention strategies are reviewed.
No takes yet. Share an insight, caveat, or question.
Jia et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: